Observed Signal · Sep 16, 2026 · Market Report · Source: PR Newswire: Technology News · Impact: 1/5 · Sentiment: Positive
Diagnostic Imaging Market to Grow to $33.2B by 2031
A new Wissen Research report projects the global diagnostic imaging market to grow from $26.5 billion in 2026 to $33.2 billion by 2031, a 4.6% CAGR. Growth is driven by chronic disease prevalence, an aging population, and demand for early detection. Key trends include AI embedded directly into imaging acquisition (deep learning reconstruction), cloud-native PACS and teleradiology, photon-counting CT, and portable devices. However, reimbursement compression (e.g., CMS 2026 fee schedule adjustments) and high equipment costs pose challenges. Recent developments include GE HealthCare's SIGNA MRI launch, Siemens Healthineers' CT-guided intervention workflow, Samsung Medison's consolidation under HME America, and Fujifilm's ARIETTA Deep Insight x ultrasound platform.
The article is a market research report on diagnostic imaging, which is not directly relevant to the AdTech/MarTech/Advertising/AI industry.
Track FUJIFILM Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Global diagnostic imaging market projected to grow from USD 26.5 billion in 2026 to USD 33.2 billion by 2031.
- Market expected to register a CAGR of 4.6% during 2026-2031.
- CMS 2026 Medicare Physician Fee Schedule introduces a 2.5% permanent reduction in work RVUs across roughly 7,700 codes.
- GE HealthCare introduced next-generation SIGNA MRI technologies at ISMRM 2026.
- Fujifilm launched ARIETTA Deep Insight x ultrasound platform in February 2026.
Connected Companies & Entities
2 Entities mapped“Fujifilm Holdings launched the ARIETTA Deep Insight x ultrasound platform....”
“Key player in enterprise imaging, cloud PACS, and AI-enabled platforms....”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Data Centers, Chips, Energy Drive AI Investment to New Heights
A PwC report forecasts global AI infrastructure investments could reach $31.6 trillion by 2050, driven by data centers, chips, and energy. Annual investment is projected to grow from $800 billion in 2026 to $1.8 trillion by 2050. ICT equipment will account for up to 93% of investments, with recurring chip upgrades sustaining expenditure. The US is expected to attract nearly half of total investments, while digital sovereignty strategies influence capital flows. Export controls could reduce cumulative investments by $6 trillion under a restrictive scenario.
Clinical Trial Supplies Market to Reach $8.95B by 2031
MarketsandMarkets forecasts the clinical trial supplies market to grow from USD 5.60 billion in 2026 to USD 8.95 billion by 2031, at a CAGR of 8.9%. The report highlights logistics and distribution as the largest service segment, small molecules as the dominant molecule type, and oncology as the leading therapeutic area. North America accounts for over 41.4% of global revenue. Key drivers include rising clinical trial numbers, increased R&D spending, and decentralized trial adoption. The report also details major M&A activity, including DHL's acquisition of CRYOPDP and UPS's acquisition of Andlauer Healthcare Group, reflecting consolidation in cold-chain logistics.
AI Infrastructure Funding Gap Threatens Industry by 2031
Bain & Company's Global Technology Report warns that the AI industry faces a yearly funding gap of $4.2 trillion by 2031 due to massive infrastructure investments. Spending on AI infrastructure is set to explode to $1.5 trillion annually within five years, including new data centers and upgrades. For profitability, these costs should be at most a quarter of total revenue, implying AI-related revenue must reach $6 trillion by 2031. However, current consumer products and ad revenue may only generate $200-400 billion, with enterprise contributions up to $1-1.4 trillion. Bain suggests new revenue sources like search, advertising, AI robots, autonomous vehicles, and devices could contribute $1.5 trillion, but the remaining $2.7 trillion requires yet-to-be-developed innovations like AI drug discovery or materials science. The report criticizes overbuilding infrastructure before demand materializes.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.